{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T15:32:52Z","timestamp":1773675172563,"version":"3.50.1"},"reference-count":73,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007623","name":"Emory University School of Medicine","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007623","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Atlanta Pediatric Scholars Program (APSP)","award":["K12HD072245"],"award-info":[{"award-number":["K12HD072245"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.iac.2018.08.003","type":"journal-article","created":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T17:42:39Z","timestamp":1541094159000},"page":"113-128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Update on Advances in Hematopoietic Cell Transplantation for Primary Immunodeficiency Disorders"],"prefix":"10.1016","volume":"39","author":[{"given":"Oded","family":"Shamriz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanmuganathan","family":"Chandrakasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.iac.2018.08.003_bib1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12016-013-8384-9","article-title":"Historical perspectives in the diagnosis and treatment of primary immune deficiencies","volume":"46","author":"Ballow","year":"2014","journal-title":"Clin Rev Allergy Immunol"},{"issue":"5","key":"10.1016\/j.iac.2018.08.003_bib2","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s12098-015-2012-z","article-title":"Hematopoietic stem cell transplantation for primary immune deficiency disorders","volume":"83","author":"Kapoor","year":"2016","journal-title":"Indian J Pediatr"},{"issue":"1","key":"10.1016\/j.iac.2018.08.003_bib3","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s10875-017-0455-x","article-title":"Newborn screening for primary immunodeficiency diseases: history, current and future practice","volume":"38","author":"King","year":"2018","journal-title":"J\u00a0Clin Immunol"},{"issue":"3","key":"10.1016\/j.iac.2018.08.003_bib4","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s10875-018-0489-8","article-title":"Use of genetic testing for primary immunodeficiency patients","volume":"38","author":"Heimall","year":"2018","journal-title":"J\u00a0Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2018.08.003_bib5","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s10875-017-0464-9","article-title":"International Union of Immunological Societies: 2017 primary immunodeficiency diseases committee report on inborn errors of immunity","volume":"38","author":"Picard","year":"2018","journal-title":"J\u00a0Clin Immunol"},{"issue":"9","key":"10.1016\/j.iac.2018.08.003_bib6","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1182\/blood-2016-01-696385","article-title":"Stem cell transplantation for tetratricopeptide repeat domain 7A deficiency: long-term follow-up","volume":"128","author":"Kammermeier","year":"2016","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.iac.2018.08.003_bib7","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1182\/blood-2017-03-771600","article-title":"Hematopoietic stem cell transplantation in 29 patients hemizygous for hypomorphic IKBKG\/NEMO mutations","volume":"130","author":"Miot","year":"2017","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.iac.2018.08.003_bib8","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1097\/TP.0000000000000975","article-title":"Allogeneic hematopoietic stem cell transplantation in the treatment of human c1q deficiency: the Karolinska experience","volume":"100","author":"Olsson","year":"2016","journal-title":"Transplantation"},{"issue":"6246","key":"10.1016\/j.iac.2018.08.003_bib9","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.aaa1663","article-title":"Autoimmune disease. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy","volume":"349","author":"Lo","year":"2015","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.iac.2018.08.003_bib10","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.jaci.2016.11.022","article-title":"Ruxolitinib reverses dysregulated T helper cell responses and controls autoimmunity caused by a novel signal transducer and activator of transcription 1 (STAT1) gain-of-function mutation","volume":"139","author":"Weinacht","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2018.08.003_bib11","first-page":"1","article-title":"2017 LASID meeting abstracts","year":"2017","journal-title":"J\u00a0Clin Immunol"},{"issue":"5","key":"10.1016\/j.iac.2018.08.003_bib12","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s10875-008-9196-1","article-title":"Use of sirolimus in IPEX and IPEX-like children","volume":"28","author":"Yong","year":"2008","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.iac.2018.08.003_bib13","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3389\/fimmu.2018.00543","article-title":"Disease evolution and response to rapamycin in activated phosphoinositide 3-kinase delta syndrome: the European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase delta Syndrome Registry","volume":"9","author":"Maccari","year":"2018","journal-title":"Front Immunol"},{"issue":"21","key":"10.1016\/j.iac.2018.08.003_bib14","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1182\/blood-2017-08-801191","article-title":"Effective \"activated PI3Kdelta syndrome\"-targeted therapy with the PI3Kdelta inhibitor leniolisib","volume":"130","author":"Rao","year":"2017","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.iac.2018.08.003_bib15","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1053\/j.gastro.2016.08.055","article-title":"Interleukin 1beta mediates intestinal inflammation in mice and patients with interleukin 10 receptor deficiency","volume":"151","author":"Shouval","year":"2016","journal-title":"Gastroenterology"},{"issue":"9915","key":"10.1016\/j.iac.2018.08.003_bib16","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0140-6736(13)62069-3","article-title":"Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study","volume":"383","author":"Gungor","year":"2014","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.iac.2018.08.003_bib17","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1182\/blood-2010-10-312082","article-title":"Treosulfan-based conditioning regimens for hematopoietic stem cell transplantation in children with primary immunodeficiency: United Kingdom experience","volume":"117","author":"Slatter","year":"2011","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.iac.2018.08.003_bib18","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.bbmt.2015.04.009","volume":"21","author":"Marsh","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9693","key":"10.1016\/j.iac.2018.08.003_bib19","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/S0140-6736(09)60945-4","article-title":"Haemopoietic stem-cell transplantation with antibody-based minimal-intensity conditioning: a phase 1\/2 study","volume":"374","author":"Straathof","year":"2009","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.iac.2018.08.003_bib20","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.bbmt.2014.05.014","article-title":"Radiolabeled anti-CD45 antibody with reduced-intensity conditioning and allogeneic transplantation for younger patients with advanced acute myeloid leukemia or myelodysplastic syndrome","volume":"20","author":"Mawad","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5854","key":"10.1016\/j.iac.2018.08.003_bib21","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1126\/science.1149726","article-title":"Efficient transplantation via antibody-based clearance of hematopoietic stem cell niches","volume":"318","author":"Czechowicz","year":"2007","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.iac.2018.08.003_bib22","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1182\/blood-2015-12-689083","article-title":"KIT blockade is sufficient for donor hematopoietic stem cell engraftment in Fanconi anemia mice","volume":"129","author":"Chandrakasan","year":"2017","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.iac.2018.08.003_bib23","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/nbt.3584","article-title":"Non-genotoxic conditioning for hematopoietic stem cell transplantation using a hematopoietic-cell-specific internalizing immunotoxin","volume":"34","author":"Palchaudhuri","year":"2016","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.iac.2018.08.003_bib24","unstructured":"Shizuru JA. AMG191 conditioning\/CD34+CD90 stem cell transplant study for SCID patients. 2016. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02963064. Accessed November 15, 2016."},{"issue":"5","key":"10.1016\/j.iac.2018.08.003_bib25","first-page":"1690","volume":"96","author":"Locatelli","year":"2000","journal-title":"Blood"},{"issue":"1\u20133","key":"10.1016\/j.iac.2018.08.003_bib26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s12026-009-8139-0","article-title":"High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantation","volume":"47","author":"Luznik","year":"2010","journal-title":"Immunol Res"},{"issue":"2","key":"10.1016\/j.iac.2018.08.003_bib27","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1053\/j.seminhematol.2016.01.005","article-title":"Haploidentical bone marrow and stem cell transplantation: experience with post-transplantation cyclophosphamide","volume":"53","author":"Robinson","year":"2016","journal-title":"Semin Hematol"},{"issue":"1","key":"10.1016\/j.iac.2018.08.003_bib28","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/bmt.2013.114","article-title":"Depletion of naive T\u00a0cells using clinical grade magnetic CD45RA beads: a new approach for GVHD prophylaxis","volume":"49","author":"Teschner","year":"2014","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.iac.2018.08.003_bib29","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1182\/blood-2014-03-563817","article-title":"HLA-haploidentical stem cell transplantation after removal of \u03b1\u03b2+ T and B cells in children with nonmalignant disorders","volume":"124","author":"Bertaina","year":"2014","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.iac.2018.08.003_bib30","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.prp.2011.10.006","article-title":"Transplantation in the onco-hematology field: focus on the manipulation of \u03b1\u03b2 and \u03b3\u03b4 T\u00a0cells","volume":"208","author":"Daniele","year":"2012","journal-title":"Pathol Res Pract"},{"issue":"1\u20132","key":"10.1016\/j.iac.2018.08.003_bib31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.imlet.2013.09.027","article-title":"Negative depletion of \u03b1\/\u03b2+ T\u00a0cells and of CD19+ B lymphocytes: a novel frontier to optimize the effect of innate immunity in HLA-mismatched hematopoietic stem cell transplantation","volume":"155","author":"Locatelli","year":"2013","journal-title":"Immunol Lett"},{"issue":"4","key":"10.1016\/j.iac.2018.08.003_bib32","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.jaci.2017.07.008","article-title":"T-cell receptor alphabeta(+) and CD19(+) cell-depleted haploidentical and mismatched hematopoietic stem cell transplantation in primary immune deficiency","volume":"141","author":"Shah","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.iac.2018.08.003_bib33","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1056\/NEJM198502283120901","article-title":"Adenovirus infections in patients undergoing bone-marrow transplantation","volume":"312","author":"Shields","year":"1985","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.iac.2018.08.003_bib34","first-page":"377","article-title":"Risk factors for developing EBV-related B cell lymphoproliferative disorders (BLPD) after non-HLA-identical BMT in children","volume":"18","author":"Gerritsen","year":"1996","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"10.1016\/j.iac.2018.08.003_bib35","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective","volume":"15","author":"Tomblyn","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"10.1016\/j.iac.2018.08.003_bib36","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1097\/01.tp.0000209195.95115.8e","article-title":"Cidofovir for the treatment of adenoviral infection in pediatric hematopoietic stem cell transplant patients","volume":"81","author":"Yusuf","year":"2006","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.iac.2018.08.003_bib37","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1046\/j.1365-2141.2001.03041.x","article-title":"Chimaeric anti-CD20 monoclonal antibody (rituximab) in post-transplant B-lymphoproliferative disorder following stem cell transplantation in children","volume":"115","author":"Faye","year":"2001","journal-title":"Br J Haematol"},{"issue":"26","key":"10.1016\/j.iac.2018.08.003_bib38","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1182\/blood-2016-01-628982","article-title":"T\u00a0cells for viral infections after allogeneic hematopoietic stem cell transplant","volume":"127","author":"Bollard","year":"2016","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.iac.2018.08.003_bib39","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.jaci.2015.12.1311","article-title":"Adoptive immunotherapy for primary immunodeficiency disorders with virus-specific T lymphocytes","volume":"137","author":"Naik","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2018.08.003_bib40","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.3389\/fimmu.2017.01470","article-title":"A\u00a0practical approach to newborn screening for severe combined immunodeficiency using the T\u00a0cell receptor excision circle assay","volume":"8","author":"Thakar","year":"2017","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.iac.2018.08.003_bib41","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.bbmt.2017.04.026","volume":"23","author":"Heimall","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1016\/j.iac.2018.08.003_bib42","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1182\/blood-2009-01-199323","article-title":"Thymic output, T-cell diversity, and T-cell function in long-term human SCID chimeras","volume":"114","author":"Sarzotti-Kelsoe","year":"2009","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.iac.2018.08.003_bib43","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s10875-012-9797-6","article-title":"Post-transplantation B cell function in different molecular types of SCID","volume":"33","author":"Buckley","year":"2013","journal-title":"J\u00a0Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2018.08.003_bib44","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/ACI.0000000000000115","article-title":"Stem cell transplantation for primary immunodeficiency diseases: the North American experience","volume":"14","author":"Pai","year":"2014","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"15","key":"10.1016\/j.iac.2018.08.003_bib45","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1056\/NEJMoa1404588","article-title":"A\u00a0modified gamma-retrovirus vector for X-linked severe combined immunodeficiency","volume":"371","author":"Hacein-Bey-Abina","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"26","key":"10.1016\/j.iac.2018.08.003_bib46","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1182\/blood-2017-10-809822","article-title":"B\u00a0cell differentiation and IL-21 response in IL2RG\/JAK3 SCID patients after hematopoietic stem cell transplantation","volume":"131","author":"Miggelbrink","year":"2018","journal-title":"Blood"},{"issue":"335","key":"10.1016\/j.iac.2018.08.003_bib47","doi-asserted-by":"crossref","first-page":"335ra357","DOI":"10.1126\/scitranslmed.aad8856","article-title":"Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency","volume":"8","author":"De Ravin","year":"2016","journal-title":"Sci Transl Med"},{"issue":"25","key":"10.1016\/j.iac.2018.08.003_bib48","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1182\/blood-2017-05-781849","article-title":"Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study","volume":"130","author":"Heimall","year":"2017","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.iac.2018.08.003_bib49","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.jaci.2017.03.020","article-title":"Thymus transplantation for complete DiGeorge syndrome: European experience","volume":"140","author":"Davies","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2018.08.003_bib50","doi-asserted-by":"crossref","first-page":"252460","DOI":"10.1155\/2012\/252460","article-title":"Current concepts of hyperinflammation in chronic granulomatous disease","volume":"2012","author":"Rieber","year":"2012","journal-title":"Clin Dev Immunol"},{"issue":"3","key":"10.1016\/j.iac.2018.08.003_bib51","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1182\/blood-2016-03-704015","article-title":"Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience","volume":"128","author":"Morillo-Gutierrez","year":"2016","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.iac.2018.08.003_bib52","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/j.bbmt.2016.08.013","article-title":"A\u00a0single-center experience comparing alemtuzumab, fludarabine, and melphalan reduced-intensity conditioning with myeloablative busulfan, cyclophosphamide, and antithymocyte globulin for chronic granulomatous disease","volume":"22","author":"Khandelwal","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"10.1016\/j.iac.2018.08.003_bib53","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.bbmt.2010.12.714","article-title":"Allogeneic hematopoietic stem cell transplantation in leukocyte adhesion deficiency type 1: a single center experience","volume":"17","author":"Al-Dhekri","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.iac.2018.08.003_bib54","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1542\/peds.2008-1191","article-title":"Allogeneic hematopoietic stem-cell transplantation for leukocyte adhesion deficiency","volume":"123","author":"Qasim","year":"2009","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.iac.2018.08.003_bib55","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1097\/MOP.0000000000000029","article-title":"Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) and IPEX-related disorders: an evolving web of heritable autoimmune diseases","volume":"25","author":"Verbsky","year":"2013","journal-title":"Curr Opin Pediatr"},{"issue":"3","key":"10.1016\/j.iac.2018.08.003_bib56","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.jaci.2017.10.041","article-title":"Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: an international multicenter retrospective study","volume":"141","author":"Barzaghi","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2018.08.003_bib57","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jaci.2017.03.049","article-title":"Hematopoietic stem cell transplantation in patients with gain-of-function signal transducer and activator of transcription 1 mutations","volume":"141","author":"Leiding","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2018.08.003_bib58","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jaci.2017.04.023","article-title":"Treatment of severe forms of LPS-responsive beige-like anchor protein deficiency with allogeneic hematopoietic stem cell transplantation","volume":"141","author":"Seidel","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2018.08.003_bib59","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jaci.2016.01.045","article-title":"Hematopoietic stem cell transplantation for CTLA4 deficiency","volume":"138","author":"Slatter","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.iac.2018.08.003_bib60","doi-asserted-by":"crossref","first-page":"e78664","DOI":"10.1371\/journal.pone.0078664","article-title":"Autoantibodies to harmonin and villin are diagnostic markers in children with IPEX syndrome","volume":"8","author":"Lampasona","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.iac.2018.08.003_bib61","first-page":"554","article-title":"Very-early-onset inflammatory bowel disease","volume":"11","author":"Snapper","year":"2015","journal-title":"Gastroenterol Hepatol (N Y)"},{"issue":"9","key":"10.1016\/j.iac.2018.08.003_bib62","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/ecco-jcc\/jjy068","article-title":"Diagnostic yield of next-generation sequencing in very early-onset inflammatory bowel diseases: a multicenter study","volume":"12","author":"Charbit-Henrion","year":"2018","journal-title":"J\u00a0Crohns Colitis"},{"issue":"2","key":"10.1016\/j.iac.2018.08.003_bib63","doi-asserted-by":"crossref","first-page":"65","DOI":"10.14740\/gr740w","article-title":"IL-10 and IL-10 receptor mutations in very early onset inflammatory bowel disease","volume":"10","author":"Zhu","year":"2017","journal-title":"Gastroenterology Res"},{"issue":"3","key":"10.1016\/j.iac.2018.08.003_bib64","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jaci.2012.09.025","article-title":"Clinical outcome in IL-10- and IL-10 receptor-deficient patients with or without hematopoietic stem cell transplantation","volume":"131","author":"Engelhardt","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2018.08.003_bib65","article-title":"Hematopoietic stem cell transplantation from unrelated donors in 2 cases of interleukin-10 receptor deficiency: is surgery not a requirement?","author":"Kocacik Uygun","year":"2018","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"issue":"8","key":"10.1016\/j.iac.2018.08.003_bib66","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/ni.3777","article-title":"The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation","volume":"18","author":"Manthiram","year":"2017","journal-title":"Nat Immunol"},{"issue":"11","key":"10.1016\/j.iac.2018.08.003_bib67","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/ni1117-1271a","article-title":"Corrigendum: The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation","volume":"18","author":"Manthiram","year":"2017","journal-title":"Nat Immunol"},{"issue":"3","key":"10.1016\/j.iac.2018.08.003_bib68","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1182\/blood-2002-02-0651","article-title":"Allogeneic bone marrow transplantation: cure for familial Mediterranean fever","volume":"100","author":"Milledge","year":"2002","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.iac.2018.08.003_bib69","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1182\/blood-2002-10-3066","article-title":"Should patients with FMF undergo BMT?","volume":"101","author":"Touitou","year":"2003","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.iac.2018.08.003_bib70","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1182\/blood-2003-04-1105","article-title":"Allogenic bone marrow transplantation: not a treatment yet for familial Mediterranean fever","volume":"102","author":"Touitou","year":"2003","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.iac.2018.08.003_bib71","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1182\/blood-2012-06-432500","article-title":"Allogeneic hematopoietic cell transplantation for XIAP deficiency: an international survey reveals poor outcomes","volume":"121","author":"Marsh","year":"2013","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.iac.2018.08.003_bib72","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1182\/bloodadvances.2017014449","article-title":"Allogeneic hematopoietic stem cell transplantation for severe, refractory juvenile idiopathic arthritis","volume":"2","author":"M F Silva","year":"2018","journal-title":"Blood Adv"},{"issue":"5","key":"10.1016\/j.iac.2018.08.003_bib73","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/ard.2006.061853","article-title":"Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study","volume":"66","author":"de Jager","year":"2007","journal-title":"Ann Rheum Dis"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856118300730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856118300730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:42:05Z","timestamp":1760179325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856118300730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0889856118300730"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2018.08.003","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update on Advances in Hematopoietic Cell Transplantation for Primary Immunodeficiency Disorders","name":"articletitle","label":"Article Title"},{"value":"Immunology and Allergy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iac.2018.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}